A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 78
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : VES
Long Form : vitamin E succinate
No. Year Title Co-occurring Abbreviation
2019 Anti-Cancer Effects of Sulfasalazine and Vitamin E Succinate in MDA-MB 231 Triple-Negative Breast Cancer Cells. SSZ, TNBCs
2019 Investigation on vitamin e succinate based intelligent hyaluronic acid micelles for overcoming drug resistance and enhancing anticancer efficacy. EPR, HA, MDR, P-gp, PTX, VE
2019 Vitamin E succinate-grafted-chitosan/chitosan oligosaccharide mixed micelles loaded with C-DMSA for Hg2+ detection and detoxification in rat liver. CS
2018 Comparison of hyaluronic acid-based micelles and polyethylene glycol-based micelles on reversal of multidrug resistance and enhanced anticancer efficacy in vitro and in vivo. CUR, DOX, HA, HA VES, PEG
2017 A Microwave Flow Detector for Gradient Elution Liquid Chromatography. DTA, LC, MDQ, MIM, SNR, VD3, VNA
2017 Akt/AMPK/mTOR pathway was involved in the autophagy induced by vitamin E succinate in human gastric cancer SGC-7901 cells. Akt, AMPK, mTOR, siRNA
2017 Novel dual VES phospholipid self-assembled liposomes with an extremely high drug loading efficiency. DCC, di-VES-GPC, DLS, GPC, TEM
2017 Vitamin E Succinate-Grafted-Chitosan Oligosaccharide/RGD-Conjugated TPGS Mixed Micelles Loaded with Paclitaxel for U87MG Tumor Therapy. CSO, PTX, VES-g-CSO
2016 alpha-Tocopheryl Succinate Affects Malignant Cell Viability, Proliferation, and Differentiation. ---
10  2016 Design and Validation of PEG-Derivatized Vitamin E Copolymer for Drug Delivery into Breast Cancer. CMC, DLC, PAMV6, PEG
11  2016 The effect of dual-functional hyaluronic acid-vitamin E succinate micelles on targeting delivery of doxorubicin. DOX, DS, HA
12  2016 Vitamin E succinate induces apoptosis via the PI3K/AKT signaling pathways in EC109 esophageal cancer cells. PI3K
13  2015 Effect of vitamin E succinate on the expression of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor in gastric cancer cells and CD4(+) T cells. DR4, DR5, TRAIL
14  2015 Enhanced cellular uptake and intracellular drug controlled release of VESylated gemcitabine prodrug nanocapsules. dFdC, DLS, TEM
15  2015 Preparation of intravenous injection nanoformulation of VESylated gemcitabine by co-assembly with TPGS and its anti-tumor activity in pancreatic tumor-bearing mice. dFdC, DLS, TEM, TPGS
16  2015 Protective Macroautophagy Is Involved in Vitamin E Succinate Effects on Human Gastric Carcinoma Cell Line SGC-7901 by Inhibiting mTOR Axis Phosphorylation. 3-MA, CQ, GFP-LC3, mTOR
17  2015 Shrapnel nanoparticles loading docetaxel inhibit metastasis and growth of breast cancer. DTX, MMPs, PPV, PSV
18  2015 Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery: probing the effect of uncovalent pegylation degree on cellular uptake and blood long circulation. ADA-PEG, DOX, HA, NPs, PEG
19  2012 Vitamin E succinate inhibits survivin and induces apoptosis in pancreatic cancer cells. ---
20  2010 The effect of vitamin e succinate on ischemia reperfusion injury. I/R, ROS
21  2010 Vitamin E succinate (VES) inhibits cell growth and induces apoptosis by mitochondrial-derived ROS in SGC-7901 cells. ROS
22  2009 alpha-Tocopheryl succinate and derivatives mediate the transcriptional repression of androgen receptor in prostate cancer cells by targeting the PP2A-JNK-Sp1-signaling axis. AR, JNKs, PP2A
23  2009 In vitro and in vivo anticancer effects of the novel vitamin E ether analogue RRR-alpha-tocopheryloxybutyl sulfonic acid in prostate cancer. ---
24  2009 RRR-alpha-vitamin E succinate potentiates the antitumor effect of calcitriol in prostate cancer without overt side effects. ---
25  2008 Influence of plasticizers on the stability and release of a prodrug of Delta(9)-tetrahydrocannabinol incorporated in poly (ethylene oxide) matrices. ATBC, PEG 8000, PEO, TEC, THC-HG
26  2008 Vitamin E succinate induces NAG-1 expression in a p38 kinase-dependent mechanism. NAG-1
27  2008 [The study of apoptosis induction effect of vitamin E succinate on Tca8113 human tongue cancer cells]. FCM, MTT
28  2007 The roles of alpha-vitamin E and its analogues in prostate cancer. ---
29  2007 The therapeutic and preventive effect of RRR-alpha-vitamin E succinate on prostate cancer via induction of insulin-like growth factor binding protein-3. IGFBP-3, TRAMP
30  2007 Vitamin E succinate in combination with mda-7 results in enhanced human ovarian tumor cell killing through modulation of extrinsic and intrinsic apoptotic pathways. Ad-mda7
31  2006 Chemical stabilization of a Delta9-tetrahydrocannabinol prodrug in polymeric matrix systems produced by a hot-melt method: role of microenvironment pH. PEG, PEO
32  2006 Chemical stabilization of a Delta9-tetrahydrocannabinol prodrug in polymeric matrix systems produced by a hot-melt method: Role of microenvironment pH. PEG, PEO, THC
33  2006 The effects of ellagic acid and vitamin E succinate on antioxidant enzymes activities and glutathione levels in different brain regions of rats after subchronic exposure to TCDD. BS, CAT, CC, EA, GSH-Px, ROS, SOD, TCDD
34  2006 Vitamin E succinate suppresses prostate tumor growth by inducing apoptosis. VE
35  2005 Vitamin E succinate decreases lung cancer tumor growth in mice. i.p
36  2005 [Roles of mitochondria in vitamin E succinate-induced apoptosis in human gastric cancer SGC-7901 cells]. ---
37  2004 1,25-dihydroxycholecalciferol inhibits apoptosis in C3H10T1/2 murine fibroblast cells through activation of nuclear factor kappaB. NF-kappaB, PAK1, PI3K
38  2004 Anti-inflammatory drug delivery from hyaluronic acid hydrogels. BSA, DVS, HA, PBMC, TCPS, TNF-alpha
39  2004 c-Jun N-terminal kinase is required for vitamin E succinate-induced apoptosis in human gastric cancer cells. DAPI, DN-JNK, JNK, UT
40  2004 Differential response of human ovarian cancer cells to induction of apoptosis by vitamin E Succinate and vitamin E analogue, alpha-TEA. ---
41  2004 Effects of vitamin E succinate on the expression of Fas and PCNA proteins in human gastric carcinoma cells and its clinical significance. ---
42  2004 The extraordinary antioxidant activity of vitamin E phosphate. all-rac-VE, LPO, VE, VEA, VEP
43  2004 The modulatory effects of ellagic acid and vitamin E succinate on TCDD-induced oxidative stress in different brain regions of rats after subchronic exposure. BS, CC, EA, LP, SA, SSBs, TCDD
44  2004 Vitamin E and breast cancer. ---
45  2003 1,25-dihydroxyvitamin D inhibits vitamin E succinate-induced apoptosis in C3H10T1/2 cells but not Harvey ras-transfected cells. VDR
46  2003 [Effect of apoptosis induced by different vitamin E homologous analogues in human hepatoma cells (HepG2)]. delta-T, FCM
47  2003 [Effect of apoptosis induced by different vitamin E homologous analogues in human hepatoma cells(HepG2)]. alpha-T, delta-T, FCM, gammaT
48  2003 [Effect of different vitamin E homologous analogues on human hepatoma cell HepG2 proliferation in vitro]. alpha-T, delta-T, FCM, gammaT
49  2003 [Roles of ERK1/2 MAPK in vitamin E succinate-induced apoptosis in human gastric cancer SGC-7901 cells]. ---
50  2003 [The expression and activity of caspase-8 in the process of vitamin E succinate-induced apoptosis in human gastric carcinoma SGC-7901 cells]. ---
51  2002 Expression of p21WAF1 is dependent on the activation of ERK during vitamin E-succinate-induced monocytic differentiation. ERK
52  2002 Inhibition of angiogenesis and promotion of melanoma dormancy by vitamin E succinate. VEGF
53  2002 The effects of vitamin E succinate on the expression of c-jun gene and protein in human gastric cancer SGC-7901 cells. ---
54  2002 Vitamin E inhibits melanoma growth in mice. ---
55  2002 Vitamin E succinate inhibits colon cancer liver metastases. ---
56  2001 Activation of PKC but not of ERK is required for vitamin E-succinate-induced apoptosis of HL-60 cells. ---
57  2001 Retinoic acid and vitamin E modulate expression and release of CD178 in carcinoma cells: consequences for induction of apoptosis in CD95-sensitive cells. RA
58  2000 Peptide YY and vitamin E inhibit hormone-sensitive and -insensitive breast cancer cells. ---
59  2000 Peptide YY augments gross inhibition by vitamin E succinate of human pancreatic cancer cell growth. PYY
60  2000 Vitamin E succinate promotes breast cancer tumor dormancy. VEGF
61  2000 [Inhibition of human gastric carcinoma cell growth by vitamin E succinate]. ---
62  2000 [Study on vitamin E succinate inducing apoptosis of human gastric carcinoma cell]. ---
63  1999 Biphasic action of vitamin E on the growth of human oral squamous carcinoma cells. ---
64  1999 Estradiol modulates breast cancer cell apoptosis: a novel nongenomic steroid action relevant to carcinogenesis. E2-BSA
65  1999 Vitamin E succinate (VES) induces Fas sensitivity in human breast cancer cells: role for Mr 43,000 Fas in VES-triggered apoptosis. ---
66  1998 Protective effects of grape seed proanthocyanidins and selected antioxidants against TPA-induced hepatic and brain lipid peroxidation and DNA fragmentation, and peritoneal macrophage activation in mice. GSPE, TPA
67  1998 Protective effects of zinc salts on TPA-induced hepatic and brain lipid peroxidation, glutathione depletion, DNA damage and peritoneal macrophage activation in mice. TPA
68  1998 RRR-alpha-tocopheryl succinate induction of prolonged activation of c-jun amino-terminal kinase and c-jun during induction of apoptosis in human MDA-MB-435 breast cancer cells. AP-1
69  1997 Involvement of activator protein-1 (AP-1) in induction of apoptosis by vitamin E succinate in human breast cancer cells. AP-1
70  1997 Oxygen free radical scavenging abilities of vitamins C and E, and a grape seed proanthocyanidin extract in vitro. GSPE
71  1997 Vitamin E succinate induces Fas-mediated apoptosis in estrogen receptor-negative human breast cancer cells. FasL
72  1997 Vitamin E succinate inhibits proliferation of BT-20 human breast cancer cells: increased binding of cyclin A negatively regulates E2F transactivation activity. ---
73  1996 RRR-alpha-tocopheryl succinate induces apoptosis in avian retrovirus-transformed lymphoid cells. DAPI
74  1995 Growth inhibition and apoptosis of RL human B lymphoma cells by vitamin E succinate and retinoic acid: role for transforming growth factor beta. RA
75  1995 RRR-alpha-tocopheryl succinate inhibits DNA synthesis and enhances the production and secretion of biologically active transforming growth factor-beta by avian retrovirus-transformed lymphoid cells. CM, TGF-beta
76  1995 RRR-alpha-tocopheryl succinate inhibits the proliferation of human prostatic tumor cells with defective cell cycle/differentiation pathways. Rb, TGF-beta
77  1995 Vitamin E succinate induction of HL-60 cell adhesion: a role for fibronectin and a 72-kDa fibronectin-binding molecule. ---
78  1993 Effects of RRR-alpha-tocopheryl succinate on IL-1 and PGE2 production by macrophages. AEV, IL-1, PECs, PGE2